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Tweet: Lower Ct values from RT-PCR tests are associated with higher risk of mortality in 
SARS-CoV2 infections.Ct values<20 was associated with 2.20 times the hazards of mortality 




A diagnosis of severe acute respiratory virus coronavirus 2 (SARS-CoV-2) disease is 
widely made by the use of reverse transcription polymerase chain reaction (RT-
PCR). When using RT-PCR, the infectivity of SARS-CoV-2 can be inferred from the 
threshold cycle (Ct) value [1]. It is best practice to confirm the validity of the standard 
curve using reference materials or in-house plasmid controls with known viral copy 
numbers [2]. As the Ct value represents the cycle number at which the signal 
breaches the threshold for positivity, a lower Ct value is indicative of a higher viral 
load. Although some studies suggest that viral load is associated with mortality and 
infectiousness [3,4], a systematic review has identified little difference in viral load 
between pre-symptomatic, asymptomatic and symptomatic patients [5]. As a result, 
the clinical relevance of viral load remains controversial, and it is not used in clinical 
practice [6]. Here, we report the relationship between the Ct value and all-cause 
mortality for people who tested positive for SARS-CoV-2 on a combined nasal and 
pharyngeal swab in the Tayside region of Scotland. This is a community cohort study 
and includes the local population of the region, as well as symptomatic health and 
social care workers tested as part of a screening programme [7]. In order to obtain 
clinical characteristics and outcomes for those who tested positive, anonymised 
record linkage was conducted between routine healthcare datasets as described 
previously [8]. All positive PCR tests from the 12th of March until the 1st of May 2020 
were included, and all deaths recorded by National Records Scotland until the 20th 
of May 2020. Approval for anonymised data linkage was granted by the local Data 
Protection Officer (Caldicott Guardian).  
 
A total of 1337 individuals testing positive for SARS-CoV-2 were recorded in NHS 
Tayside. In the laboratory, nucleic acid was extracted and a one-step RT-PCR assay 
targeting the RdRP gene using an ABI7500 as previously described. For individuals 
with multiple positive tests, the Ct value from the first of these was included, and for 
multiple tests on the same day, the test with the lowest Ct value was used. In our 
cohort, the overall median Ct value of an individual’s first positive test was 28.7 (IQR 
= 23.9–33.4). The median age of the cohort was 53 years (IQR = 40–72), and 61.9% 
were female. 202 individuals (15%) were hospitalised with COVID-19 disease 
(recorded with the ICD code for COVID-19: U07.1).  
 
Total number of deaths in the cohort were 161 (12%), the majority of deaths (102) 
occurred in a non-hospital cohort. However, a larger proportion of those hospitalised 
died (29% compared to 9% who died without hospitalisation). This is likely due to the 
high incidence of infection and deaths in care homes for the elderly.  Mean follow up 
available was 37 days (SD 14), and maximum follow up was 69 days. 15% of the 
cohort had hypertension, 4% had heart failure, 9% had ischaemic heart disease 
(IHD), 8% had chronic obstructive pulmonary disease (COPD), 5% had asthma, 8% 
had chronic kidney disease (CKD), and 10% had type 2 diabetes mellitus (T2DM).  
 
A Cox proportional hazards model adjusting for relevant clinical factors was used to 
test the association between CT value and mortality. These were: age, sex, 
hypertension, heart failure, IHD, COPD, asthma, CKD, and T2DM. The model 
showed a significant association between initial Ct value and mortality (HR 0.96 
[95% CI 0.93–0.99] p = 0.0044). Other independent predictors of mortality were age 
(HR 1.08 [95% CI 1.06–1.09] p < 0.001), and male sex (HR 1.77 [95% CI 1.28–2.44] 
p < 0.001).  
 
Ct values were then stratified into high (>30), moderate (20-30), and low (< 20), and 
a model was constructed adjusting for the same clinical factors. This showed that a 
low initial Ct value was associated with increased hazard of mortality compared to a 
high initial Ct value (HR 2.10 [95% CI 1.23-3.60] p = 0.0069), however the same 
relationship between moderate and high was not statistically significant (HR 1.37 
[95% CI 0.96-1.94] p = 0.08). We performed a sensitivity analysis adjusting for 
hospitalisation status as a marker of disease severity; in this adjusted analysis a low 
initial Ct value increased hazards of mortality by 2.20 [(95%CI: 1.28-3.76) p=0.0005]. 
These results suggest that disease severity does not confound the association 
between Ct values and mortality.  
 
Early identification of the risk that COVID-19 disease presents to an individual 
remains a challenge. Most clinical investigations for COVID-19 disease have been 
limited to hospitalised cohorts, here we are able to assess the value of Ct scores in 
the community. However, as this is a community cohort study, data from clinical 
investigations performed on hospitalised patients which help classify disease 
severity, are not available for the entire cohort. Here, we have demonstrated an 
independent relationship between the Ct value (indicative of viral load) of an 
individual’s first positive SARS-CoV-2 PCR test, and overall mortality, in which a 
lower Ct value is associated with greater hazard of death. Ct values may allow for 
early risk stratification in patients with COVID-19. Further work is required to confirm 
this association and to assess the utility of including Ct values in early risk 







1. Public Health England. Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR. 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attach
ment_data/file/926410/Understanding_Cycle_Threshold__Ct__in_SARS-CoV-2_RT-
PCR_.pdf. Date last updated: October 28 2020. Date last accessed: January 17 
2020.  
 
2. Han MS, Byun JH, Cho Y, Rim JH. RT-PCR for SARS-CoV-2: quantitative versus 
qualitative. Lancet Infect Dis. 2020 May 20:S1473-3099(20)30424-2.  
 
3. Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A, Nadkarni G, 
Glicksberg BS, Houldsworth J, Cordon-Cardo C. SARS-CoV-2 viral load predicts 
COVID-19 mortality. Lancet Respir Med. 2020 Sep;8(9):e70 
 
4. Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J, Ladhani S, 
Zambon M, Gopal R. Duration of infectiousness and correlation with RT-PCR cycle 
threshold values in cases of COVID-19, England, January to May 2020. Euro 
Surveill. 2020 Aug;25(32):2001483.  
 
5. Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, Ahern S, Carty PG, 
O'Brien KK, O'Murchu E, O'Neill M, Smith SM, Ryan M, Harrington P. SARS-CoV-2 
detection, viral load and infectivity over the course of an infection. J Infect. 2020 
Sep;81(3):357-371.  
 
6. Kelleni MT. SARS CoV-2 viral load might not be the right predictor of COVID-19 
mortality. J Infect. 2020 Aug 15:S0163-4453(20)30552-1.  
 
7. Parcell BJ, Brechin K, Allstaff S, Park M, Third W, Bean S, Hind C, Farmer R, 
Chandler D, Chalmers JD. Drive-through testing for SARS-CoV-2 in symptomatic 
health and social care workers and household members: an observational cohort 
study. Thorax. 2020 Dec;75(12):1109-1111.  
 
8. Siddiqui MK, Parcell BJ, Allstaff S, Palmer C, Chalmers JD, Bell S. Characteristics 
and outcomes of health and social care workers testing positive for SARS-CoV-2 in 








Figure 1. A. Overall survival probability for individuals positive SARS-CoV-2 in Tayside, Scotland based on the cycle threshold 
(Ct) value of their first positive test. Crosses represent censored individuals. B. Estimated hazard ratio based on initial Ct value 
of individual in a model adjusting for age, sex, hypertension, heart failure, IHD, COPD, asthma, CKD, and T2DM. 
 
 
